These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5002307)

  • 1. Antimycobacterial activity of rifampicin.
    Lucchesi M; Mancini P
    Antibiot Chemother; 1970; 16():431-43. PubMed ID: 5002307
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental and clinical studies on the antituberculous activity of rifampicin alone or combined with other drugs.
    Nitti V
    Antibiot Chemother; 1970; 16():444-70. PubMed ID: 5002308
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental studies of the antimycobacterial activity of Rifampicine].
    Nitti V; Catena E; Ninni A; Di Filippo A
    Arch Tisiol Mal Appar Respir; 1966 Nov; 21(11):867-910. PubMed ID: 4969274
    [No Abstract]   [Full Text] [Related]  

  • 4. The anti-mycobacterial activity of ethambutol (ETB).
    Lucchesi M; Mancini P
    Antibiot Chemother; 1970; 16():230-8. PubMed ID: 5002302
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug susceptibility in Mycobacterium tuberculosis of a sample of patients in Guinea Bissau.
    Dias F; Michael SG; Hoffner SE; Martins L; Norberg R; Källenius G
    Tuber Lung Dis; 1993 Apr; 74(2):129-30. PubMed ID: 8324205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activity of rifampicin on experimental tuberculosis in mice. The development of resistance to rifampicin. Therapeutic effects of combinations of different drugs with rifampicin].
    Grumbach F
    Antibiot Chemother; 1970; 16():392-405. PubMed ID: 5002305
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity to rifaximin and rifampicin of Mycobacterium tuberculosis isolated from guinea pigs treated orally with rifaximin.
    Malvisi Stracciari J; Venturini AP; Anfossi P; Marchi E; Stracciari GL
    Chemioterapia; 1987 Apr; 6(2):82-4. PubMed ID: 3109750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampicin in the retreatment and original treatment of advanced pulmonary tuberculosis.
    Gyselen A
    Bull Int Union Tuberc; 1970 Jun; 43():60-3. PubMed ID: 4987555
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of drug resistance to rifampicin.
    Manten A; Van Wijngaarden LJ
    Chemotherapy; 1969; 14(2):93-100. PubMed ID: 4979978
    [No Abstract]   [Full Text] [Related]  

  • 10. Rifampicin-susceptibility and rifampicin-resistance in mycobacteria.
    Manten A; van Wijngaarden LJ; van Klingeren B
    Acta Tuberc Pneumol Belg; 1969; 60(3):329-34. PubMed ID: 4984415
    [No Abstract]   [Full Text] [Related]  

  • 11. The pattern of resistance development to rifampicin in Mycobacterium tuberculosis.
    Tsukamura M
    Tubercle; 1972 Jun; 53(2):111-7. PubMed ID: 4625182
    [No Abstract]   [Full Text] [Related]  

  • 12. Rifampicin in experimental investigations on mice.
    Havel A; Adámek L; Simonová S
    Antibiot Chemother; 1970; 16():406-15. PubMed ID: 5002306
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rifampicin in the retreatment of severe cavitary pulmonary tuberculosis. I. Some considerations on the sputum conversion rate and the emergence of drug resistance].
    Baba H; Takahashi R; Azuma Y
    Kekkaku; 1971 Nov; 46(11):429-35. PubMed ID: 5004056
    [No Abstract]   [Full Text] [Related]  

  • 14. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A
    Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of rifampicin on experimental mouse tuberculosis].
    Yoshida F
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):35-43. PubMed ID: 4990960
    [No Abstract]   [Full Text] [Related]  

  • 16. The antimycobacterial activity of capreomycin.
    Lucchesi M
    Antibiot Chemother; 1970; 16():27-31. PubMed ID: 4108891
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rifampicin in experimental tuberculosis].
    Petrova MA; Berezina EK; Nabashin SM
    Antibiotiki; 1977 Jan; 22(1):64-8. PubMed ID: 843075
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the development of drug-resistant tubercle bacilli in experimental animal tuberculosis].
    Yamanouchi T; Sawai A; Hori M
    Kekkaku; 1973 Jul; 48(7):277-95. PubMed ID: 4200057
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term results with rifampicin together with ethambutol and-or other drugs in the treatment of tuberculosis with cultures resistant to the standard drugs.
    Pines A
    Respiration; 1971; 28():Suppl:91-6. PubMed ID: 5004832
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of in-vitro and in-vivo experiments with Mycobacterium tuberculosis in helping to plan chemotherapy regimens.
    Dickinson JM; Mitchison DA
    Tidsskr Nor Laegeforen; 1975 Jun; 95(17-18):1087-9. PubMed ID: 806991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.